Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤40years of age)

European Journal of Clinical Investigation

Volumn 42, Issue 6, 2012, Pages 631-636

  Goliasch, Georg ^a   Oravec, Stanislav ^b   Blessberger, Hermann ^a   Dostal, Elisabeth ^c   Hoke, Matthias ^a   Wojta, Johann ^a   Schillinger, Martin ^a   Huber, Kurt ^d   Maurer, Gerald ^a   Wiesbauer, Franz ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Physics and Informatics   (Slovakia)

^c Krankenanstalten Dr Dostal   (Austria)

^d WILHELMINEN HOSPITAL   (Austria)

Author keywords

Acute myocardial infarction; Lipid profile; Non HDL cholesterol; Premature coronary artery disease; Small dense LDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PREDICTION; PREMATURE CORONARY ARTERY DISEASE; PREMATURE HEART INFARCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVOR;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; INFANT; MALE; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84860918045     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02629.x     Document Type: Article

References (27)

1. Fournier JA, Cabezon S, Cayuela A, Ballesteros SM, Cortacero JA, Diaz De La Llera LS. Long-term prognosis of patients having acute myocardial infarction when ≤ 40years of age. Am J Cardiol 2004;94:989-92.
2. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med 1999;107:254-61.
3. Goliasch G, Wiesbauer F, Grafl A, Ponweiser E, Blessberger H, Tentzeris I et al. The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40years of age). Thromb Haemost 2011;105:529-34.
4. Wiesbauer F, Blessberger H, Azar D, Goliasch G, Wagner O, Gerhold L et al. Familial-combined hyperlipidaemia in very young myocardial infarction survivors (≤40years of age). Eur Heart J 2009;30:1073-9.
5. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
6. Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep 2004;6:381-7.
7. Otvos JD, Jeyarajah EJ, Cromwell WC. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol 2002;90:22i-9i.
8. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
9. El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol 2007;49:547-53.
10. Otvos JD, Collins D, Freedman DS, Shalaurova I, Schaefer EJ, McNamara JR et al. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 2006;113:1556-63.
11. Kontush A, Chapman MJ. Antiatherogenic small, dense HDL - guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med 2006;3:144-53.
12. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
13. Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
14. Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 2005;46:277-83.
15. Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 2001;47:266-74.
16. Rothman K, Greenland S. Modern Epidemiology. Philadephia: Lippincott Williams & Wilkins; 1998: pp 147-62.
17. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 1995;57:289-300.
19. Zambon A, Brown BG, Hokanson JE, Motulsky AG, Brunzell JD. Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy. J Intern Med 2006;259:401-9.
20. Sniderman AD, Castro Cabezas M, Ribalta J, Carmena R, de Bruin TW, de Graaf J et al. A proposal to redefine familial combined hyperlipidaemia - third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur J Clin Invest 2002;32:71-3.
21. Miller BD, Alderman EL, Haskell WL, Fair JM, Krauss RM. Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. Circulation 1996;94:2146-53.
22. Mykkanen L, Kuusisto J, Haffner SM, Laakso M, Austin MA. LDL size and risk of coronary heart disease in elderly men and women. Arterioscler Thromb Vasc Biol 1999;19:2742-8.
23. Rizzo M, Berneis K. Should we measure routinely the LDL peak particle size? Int J Cardiol 2006;107:166-70.
24. Rizzo M, Barbagallo CM, Severino M, Polizzi F, Onorato F, Noto D et al. Low-density-lipoprotein peak particle size in a Mediterranean population. Eur J Clin Invest 2003;33:126-33.
25. Salonen JT, Salonen R, Seppanen K, Rauramaa R, Tuomilehto J. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation 1991;84:129-39.
26. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 2005;25:2185-91.
27. Ryder RE, Hayes TM, Mulligan IP, Kingswood JC, Williams S, Owens DR. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J (Clin Res Ed) 1984;289:1651-3.